Reverse DCF
What growth does the market imply for HESTERBIO?
Working backwards from the current price to find the FCF growth assumption baked in.
aggressive
14.8% implied annual FCF growth
The market is pricing in above-average growth. Achievable for a high-quality business but leaves limited margin for error — any slowdown could hurt the price.
Current Price
₹1,496
Historical Growth
5.2%
FCF Yield
3.45%
Price / FCF
29.0x
Plain English
To justify today's price of $1496.00, HESTERBIO.NS needs to grow its free cash flow at 14.8% per year for the next 10 years. That is 9.6% faster than its historical growth rate of 5.2%. This is optimistic but not impossible for a high-quality business. The stock leaves little room for error — any slowdown could hurt the price.
Adjust Assumptions
Growth Scenarios
What the stock is worth at different growth assumptions
| Scenario | FCF Growth | Implied IV | MoS vs Price |
|---|---|---|---|
| Historical | 5.2% | ₹589 | -60.7% |
| Half implied | 7.4% | ₹740 | -50.5% |
| GDP rate | 10.0% | ₹956 | -36.1% |
| Implied | 14.8% | ₹1,496 | -0.0% |
See full DCF analysis
Bear/base/bull scenarios, sensitivity heatmap, Monte Carlo, and more.
Run Full Analysis →This is an analytical tool, not investment advice. Implied growth is a mathematical inversion of the DCF model and depends on WACC and terminal growth assumptions. YieldIQ is not registered with SEBI as an investment adviser.